Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Yoder

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Toxicology|March 27, 2018
Ototoxicity: The Radical Drum Beat and Rhythm of Cochlear Hair Cell Life and DeathDavid V Gauvin, Joshua Yoder, Zachary J Zimmermann, et al.
International Journal of Toxicology|September 25, 2018
"Not Everything That Shakes Is a Seizure": Making the Determination of Test Article-Induced Convulsions in Toxicology StudiesDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
International Journal of Toxicology|April 21, 2022
Distortion Product Otoacoustic Emission Test is Not the Test to Use in Nonclinical Safety AssessmentDavid V Gauvin, Margaret McComb, Rachel Tapp, et al.
Journal of Pharmacological and Toxicological Methods|September 21, 2017
Down for the count: The critical endpoint in ototoxicity remains the cytocochleogramDavid V Gauvin, Joshua Yoder, Andrea Koch, et al.
International Journal of Toxicology|June 22, 2019
Predicting the Need for a Tier II Ototoxicity Study From Early Renal Function DataDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
Journal of Pharmacological and Toxicological Methods|February 27, 2013
Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpointsTheodore J Baird, Marc Bailie, Daniel J Patrick, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2018
A predictive index of biomarkers for ictogenesis from tier I safety pharmacology testing that may warrant tier II EEG studiesDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Toxicology|March 27, 2018
Ototoxicity: The Radical Drum Beat and Rhythm of Cochlear Hair Cell Life and DeathDavid V Gauvin, Joshua Yoder, Zachary J Zimmermann, et al.
International Journal of Toxicology|September 25, 2018
"Not Everything That Shakes Is a Seizure": Making the Determination of Test Article-Induced Convulsions in Toxicology StudiesDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
International Journal of Toxicology|April 21, 2022
Distortion Product Otoacoustic Emission Test is Not the Test to Use in Nonclinical Safety AssessmentDavid V Gauvin, Margaret McComb, Rachel Tapp, et al.
Journal of Pharmacological and Toxicological Methods|September 21, 2017
Down for the count: The critical endpoint in ototoxicity remains the cytocochleogramDavid V Gauvin, Joshua Yoder, Andrea Koch, et al.
International Journal of Toxicology|June 22, 2019
Predicting the Need for a Tier II Ototoxicity Study From Early Renal Function DataDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
Journal of Pharmacological and Toxicological Methods|February 27, 2013
Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpointsTheodore J Baird, Marc Bailie, Daniel J Patrick, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2018
A predictive index of biomarkers for ictogenesis from tier I safety pharmacology testing that may warrant tier II EEG studiesDavid V Gauvin, Zachary J Zimmermann, Joshua Yoder, et al.
Pageof 1